More recently, NIS protein was shown to be detectable by IHC in brain metastases from breast cancer [10], and so the characteristic of abnormal NIS protein expression in breast tumours may be maintained in derivative metastases. This evidence concerns the gene SLC5A5 and breast carcinoma.